Cargando…
Membrane‐acting biomimetic peptoids against visceral leishmaniasis
Visceral leishmaniasis (VL) is among the most neglected tropical diseases in the world. Drug cell permeability is essential for killing the intracellular residing parasites responsible for VL, making cell‐permeating peptides a logical choice to address VL. Unfortunately, the limited biological stabi...
Autores principales: | Kumar, Vivek, Lin, Jennifer S., Molchanova, Natalia, Fortkort, John A., Reckmann, Carolin, Bräse, Stefan, Jenssen, Håvard, Barron, Annelise E., Chugh, Archana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989931/ https://www.ncbi.nlm.nih.gov/pubmed/36683396 http://dx.doi.org/10.1002/2211-5463.13562 |
Ejemplares similares
-
Halogenation as a tool to tune antimicrobial activity of peptoids
por: Molchanova, Natalia, et al.
Publicado: (2020) -
Anti-persister
and Anti-biofilm Activity of Self-Assembled
Antimicrobial Peptoid Ellipsoidal Micelles
por: Lin, Jennifer S., et al.
Publicado: (2022) -
Potent Antiviral Activity against HSV-1 and SARS-CoV-2 by Antimicrobial Peptoids
por: Diamond, Gill, et al.
Publicado: (2021) -
In Vivo, In Vitro, and In Silico Characterization of Peptoids as Antimicrobial Agents
por: Czyzewski, Ann M., et al.
Publicado: (2016) -
Peptoids successfully inhibit the growth of gram negative E. coli causing substantial membrane damage
por: Mojsoska, Biljana, et al.
Publicado: (2017)